Seeking Alpha
 

MusclePharm Corp. (MSLP)

- OTCQB
  • Mon, Mar. 16, 6:01 PM
    • MusclePharm (OTCQB:MSLP) Q4 results ($M): Net Revenues: 32.7 (-12.8%); Gross Profit: 25.1 (-9.7%); Operating Expenses: 23.9 (+52.2%); Operating Loss: (16.4) (-173.3%); Net Loss: (16.2) (-305.0%); Loss Per Share: (1.39) (-208.9%); Quick Assets: 1.0 (-81.5%); A/R: 16.6 (+21.2%); Inventory: 21.1 (+33.5%).
    • 2015 Guidance: Net Sales: $210M - 220M; Gross Margin: 31 - 33%.
    • This was an ugly quarter for the supposed high flier. Revenue growth was negative, inventory backed up and expenses skyrocketed. With only $1M in the bank, the company won't be able to make payroll for long.
    • Profitability remains elusive. Best case for gross margin of 33% for this year won't be enough to make money. Gross margin for 2014 was 31.6% versus 29.9% the year before, a modest increase considering the aggressive top line growth.
    | 59 Comments
  • Nov. 17, 2014, 10:52 AM
    • Sports nutrition firm MusclePharm (OTCQB:MSLP -16.1%) slumps on light turnover of 132K shares in response to its Q3 earnings report after Friday's close. EPS of $0.05 missed estimates by $0.29. Also, its cash balance is only $2.9M.
    • Management affirms its full-year revenue guidance of $185M - 195M, but revises its EPS guidance to $0.20 - 0.22.
    | 1 Comment
  • Aug. 4, 2014, 5:43 PM
    • MusclePharm Corp. (OTCQB:MSLP -0.9%) Q2 results: Net Sales: $46.7M (+831%); Gross Profit: $15.6M (+97.5%); Operating Expenses: $15.2M (+42.1%); Operating Income: $479.5K (+118.5%); Net Income: $408.3K (+166.7%); EPS: $0.03 (+108.8%).
    • Conspicuous by their absence are the company's balance of cash/cash equivalents and CF Ops. The current assets listed on the balance sheet are most certainly dominated by accounts receivable.
    • 2014 Guidance: Net sales: $185M - 195M; EPS: $0.45 - 0.50.
    | 6 Comments
  • May. 5, 2014, 10:09 AM
    • Net sales: $50.2M (+122%), operating income: $2.4M vs a loss of $0.72M, net income: $2.7M vs a loss of $7.4M, EPS: $0.23 vs ($1.78).
    • International sales: $17.2M (+176%).
    • Cash at quarter end: $5.8M.
    • 2014 guidance:
    • Net sales: $165 - 175M.
    • EPS: $0.41 - 0.51.
    • (MSLP +22.8%) shares jump in early trading on light volume.
    | 1 Comment
Visit Seeking Alpha's
MSLP vs. ETF Alternatives
Company Description
Headquartered in Denver, Colorado, MusclePharm is a rapidly expanding healthy life-style company that develops and manufactures a full line of NSF and scientifically approved nutritional supplements that are 100% free of any banned substances. Based on years of research, MusclePharm products are... More